Infection Prevention and Control
Every year, thousands of patients across the United States are impacted by the effects of hospital-onset Clostridioides difficile (C. diff) infections (HO-CDIs). In this webinar, we examine the limitations of current interventions to prevent transmission of C. diff. We also present the manner in…
Forty-nine cities and states with the highest HIV transmission rates yesterday received between $2 million and $17 million each in fiscal year 2023 grants from the Health Resources and Services Administration to diagnose, treat and prevent new HIV infections as part of a Department of Health and…
The Food and Drug Administration approved the first fecal microbiota product taken orally to prevent recurrent C. difficile infection.
Learn how Advocate Children's Hospital is managing the “immunity gap” created by social distancing to persevere through the triple threat of COVID-19, RSV and flu.
Candida auris fungal infections tripled in the United States between 2019 and 2021 to 1,471, including seven cases resistant to all antifungal treatments, according to Centers for Disease Control and Prevention data reported yesterday in the Annals of Internal Medicine.
Sources of hospital onset bacteremia (HOB), its identification, how effectively HOB can be prevented, treated and considerations for quality metrics.
March 12–18 is Patient Safety Awareness Week.
Observing an uptick in health care-associated infections during the COVID-19 pandemic, the hospital epidemiology and infection control (HEIC) team at Johns Hopkins Bayview Medical Center took action to reverse the trend.
To reduce infection rates more effectively, successful hospitals and health systems are focusing on the fundamentals. For Advocate Condell Hospital, the focus is on process improvements.
One Surgical Site Infection (SSI) is one too many for the team at MUSC Health in Charleston, South Carolina. MUSC’s mission is “Do no harm and change what’s possible”; MUSC knows that decreasing SSIs is “an absolute change that IS possible.”